*Human Pai 1 Recombinant P1 Nbd Labeled
IHUPAI1RP1NBD500UG
Select this product for Molecular Innovations name, PAI-1 (NBD P1' mutant) reports cleavage and product number, HPAI-P1NBD.Human PAI-1 Recombinant P1-NBD Labeled from Innovative Research has been recombinantly produced in E. coli and purified by affinity chromatography. This is a Frozen liquid buffered in 0.05M Sodium Phosphate; 0.1M NaCl; 1mM EDTA; pH 6.6 and a purity of >95% as determined by SDS-PAGE. More Details: Species: Human Target: PAI-1 Purification Method: Affinity purified Purity: >95% as determined by SDS-PAGE Analysis Source: E. coli Storage Conditions: -20 C Additional Information: Created by mutagenesis of the methionine residue (Met347) at the P1-P1' sissile bond to cysteine, providing a free thiol group for NBD labeling. Fluorescence emission quenched upon cleavage of the reactive center loop by a target proteinase. This product can be used as a control in applications like ELISA and Western Blot. It can be used in a wide range of in vitro applications, including blocking/inhibition, fibrinolysis, plasminogen activation, receptor binding, in hypertension studies, for protein-protein interactions, and more. At Innovative Research, we provide reliable, consistent products that deliver reliable, consistent results.
Product References
Product Disclaimer
This material is sold for in-vitro use only for manufacturing and research. This material is not suitable for human or animal use. While we make every effort to ensure the safety of our products, we recommend handling any biological materials with standard precautions as if capable of spreading infectious disease. The statements herin are offered for informational purposes only to be used solely for your consideration, investigation, and verification.
Please be aware the image pictured is for illustrative purposes only, and your product packaging and appearance may vary.
Questions? Contact us about this product!
Get in touch with our team! Please include any relevant information (product name, etc)